{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T20:44:11Z","timestamp":1754599451633,"version":"3.37.3"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-023-05483-3","type":"journal-article","created":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T15:02:54Z","timestamp":1697641374000},"page":"363-367","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pneumocystosis in a patient with rheumatoid arthritis on adalimumab therapy: a case-based review"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4338-4879","authenticated-orcid":false,"given":"Dimitris C.","family":"Kounatidis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5103-0005","authenticated-orcid":false,"given":"Vasileios","family":"Papadimitropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3372-6527","authenticated-orcid":false,"given":"Konstantinos","family":"Avramidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5450-0574","authenticated-orcid":false,"given":"Evgenia","family":"Plenga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2299-0167","authenticated-orcid":false,"given":"Ioanna","family":"Tsiara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3938-5458","authenticated-orcid":false,"given":"Elena","family":"Avgoustou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3874-5393","authenticated-orcid":false,"given":"Natalia","family":"Vallianou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2288-3863","authenticated-orcid":false,"given":"Dimitrios","family":"Vassilopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,18]]},"reference":[{"key":"5483_CR1","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1016\/j.cmi.2017.12.025","volume":"2","author":"JW Baddley","year":"2018","unstructured":"Baddley JW, Cantini F, Goletti D, G\u00f3mez-Reino JJ, Mylonakis E, San-Juan R, Fern\u00e1ndez-Ruiz M, Torre-Cisneros J (2018) ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-\u03b1 agents). Clin Microbiol Infect Suppl 2:S10\u2013S20. https:\/\/doi.org\/10.1016\/j.cmi.2017.12.025","journal-title":"Clin Microbiol Infect Suppl"},{"issue":"1","key":"5483_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s40744-017-0059-1","volume":"4","author":"Y Ito","year":"2017","unstructured":"Ito Y, Hozumi K, Okada Y, Kurimoto S (2017) Adalimumab with Methotrexate in treatment-na\u00efve japanese patients with rheumatoid arthritis at risk of progressive structural joint damage: a postmarketing observational study. Rheumatol Ther 4(1):151\u2013166. https:\/\/doi.org\/10.1007\/s40744-017-0059-1","journal-title":"Rheumatol Ther"},{"issue":"6","key":"5483_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.medin.2012.04.005","volume":"38","author":"N Montserrat Ortiz","year":"2014","unstructured":"Montserrat Ortiz N, Gormaz Torres P, JustesMateos M, Bello Rodriguez G, Vicario Izquierdo E, Le\u00f3n Vall\u00e9s M (2014) Pneumocystis jiroveci pneumonia in a Crohns disease patient treated with adalimumab. Med Intensiva 38(6):397\u2013399. https:\/\/doi.org\/10.1016\/j.medin.2012.04.005","journal-title":"Med Intensiva"},{"issue":"9","key":"5483_CR4","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.3899\/jrheum.141510","volume":"42","author":"M Tanaka","year":"2015","unstructured":"Tanaka M, Sakai R, Koike R, Harigai M (2015) Pneumocystis jirovecii pneumonia in japanese patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a pooled analysis of 3 agents. J Rheumatol 42(9):1726\u20131728. https:\/\/doi.org\/10.3899\/jrheum.141510","journal-title":"J Rheumatol"},{"issue":"4","key":"5483_CR5","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.crohns.2011.10.012","volume":"6","author":"AL Desales","year":"2012","unstructured":"Desales AL, Mendez-Navarro J, M\u00e9ndez-Tovar LJ, Ortiz-Olvera NX, Cullen G, Ocampo J, Lemus W, Tun AE, Mayoral-Zavala A, Dehesa-Violante M (2012) Pneumocystosis in a patient with Crohn\u2019s disease treated with combination therapy with adalimumab. J Crohns Colitis 6(4):483\u2013487. https:\/\/doi.org\/10.1016\/j.crohns.2011.10.012","journal-title":"J Crohns Colitis"},{"key":"5483_CR6","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/omcr\/omw025","volume":"4","author":"P Jobanputra","year":"2016","unstructured":"Jobanputra P (2016) Polyarteritis nodosa. Diagnostic challenges in a patient with cutaneous vasculitis, psoriasis, psoriatic arthritis and pancytopenia: fatal progression after treatment with G-CSF. Oxf Med Case Rep 4:86\u201390. https:\/\/doi.org\/10.1093\/omcr\/omw025","journal-title":"Oxf Med Case Rep"},{"issue":"11","key":"5483_CR7","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1111\/j.1440-1746.2010.06407.x","volume":"25","author":"IC Lawrance","year":"2010","unstructured":"Lawrance IC, Radford-Smith GL, Bampton PA, Andrews JM, Tan PK, Croft A, Gearry RB, Florin TH (2010) Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience. J Gastroenterol Hepatol 25(11):1732\u20131738. https:\/\/doi.org\/10.1111\/j.1440-1746.2010.06407.x","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"5483_CR8","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1007\/s10165-012-0796-5","volume":"23","author":"K Watanabe","year":"2013","unstructured":"Watanabe K, Sakai R, Koike R, Sakai F, Sugiyama H, Tanaka M, Komano Y, Akiyama Y, Mimura T, Kaneko M, Tokuda H, Iso T, Motegi M, Ikeda K, Nakajima H, Taki H, Kubota T, Kodama H, Sugii S, Kuroiwa T, Nawata Y, Shiozawa K, Ogata A, Sawada S, Matsukawa Y, Okazaki T, Mukai M, Iwahashi M, Saito K, Tanaka Y, Nanki T, Miyasaka N, Harigai M (2013) Clinical characteristics and risk factors for Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis receiving adalimumab: a retrospective review and case-control study of 17 patients. Mod Rheumatol 23(6):1085\u20131093. https:\/\/doi.org\/10.1007\/s10165-012-0796-5","journal-title":"Mod Rheumatol"},{"issue":"4","key":"5483_CR9","doi-asserted-by":"publisher","first-page":"e497","DOI":"10.1097\/MJT.0000000000001102","volume":"28","author":"M Al Sona","year":"2019","unstructured":"Al Sona M, Al Battah H, Salama A, Alweis R (2019) Fatal pneumocystis jirovecii pneumonia in a patient on adalimumab: a case report. Am J Ther 28(4):e497\u2013e498. https:\/\/doi.org\/10.1097\/MJT.0000000000001102","journal-title":"Am J Ther"},{"issue":"4","key":"5483_CR10","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s10165-011-0541-5","volume":"22","author":"T Koike","year":"2012","unstructured":"Koike T, Harigai M, Ishiguro N, Inokuma S, Takei S, Takeuchi T, Yamanaka H, Tanaka Y (2012) Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients. Mod Rheumatol 22(4):498\u2013508. https:\/\/doi.org\/10.1007\/s10165-011-0541-5","journal-title":"Mod Rheumatol"},{"issue":"5","key":"5483_CR11","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1080\/00365540601071867","volume":"39","author":"U Kalyoncu","year":"2007","unstructured":"Kalyoncu U, Karadag O, Akdogan A, Kisacik B, Erman M, Erguven S, Ertenli AI (2007) Pneumocystis carinii pneumonia in a rheumatoid arthritis patient treated with adalimumab. Scand J Infect Dis 39(5):475\u2013478. https:\/\/doi.org\/10.1080\/00365540601071867","journal-title":"Scand J Infect Dis"},{"issue":"11","key":"5483_CR12","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/nrrheum.2010.154","volume":"6","author":"T Takeuchi","year":"2010","unstructured":"Takeuchi T, Kameda H (2010) The Japanese experience with biologic therapies for rheumatoid arthritis. Nat Rev Rheumatol 6(11):644\u2013652. https:\/\/doi.org\/10.1038\/nrrheum.2010.154","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"5483_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.riam.2019.09.001","volume":"37","author":"FJ Candel","year":"2020","unstructured":"Candel FJ, Pe\u00f1uelas M, Tabares C, Garcia-Vidal C, Matesanz M, Salavert M, Rivas P, Pem\u00e1n J (2020) Fungal infections following treatment with monoclonal antibodies and other immunomodulatory therapies. Rev Iberoam Micol 37(1):5\u201316. https:\/\/doi.org\/10.1016\/j.riam.2019.09.001","journal-title":"Rev Iberoam Micol"},{"issue":"4","key":"5483_CR14","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2169\/internalmedicine.50.4508","volume":"50","author":"H Kameda","year":"2011","unstructured":"Kameda H, Tokuda H, Sakai F, Johkoh T, Mori S, Yoshida Y, Takayanagi N, Taki H, Hasegawa Y, Hatta K, Yamanaka H, Dohi M, Hashimoto S, Yamada H, Kawai S, Takeuchi T, Tateda K, Goto H (2011) Clinical and radiological features of acute-onset diffuse interstitial lung diseases in patients with rheumatoid arthritis receiving treatment with biological agents: importance of Pneumocystis pneumonia in Japan revealed by a multicenter study. Intern Med 50(4):305\u2013313. https:\/\/doi.org\/10.2169\/internalmedicine.50.4508","journal-title":"Intern Med"},{"issue":"3","key":"5483_CR15","first-page":"217","volume":"71","author":"G Brown","year":"2018","unstructured":"Brown G (2018) Cotrimoxazole-induced tremor. Can J Hosp Pharm 71(3):217\u2013218","journal-title":"Can J Hosp Pharm"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05483-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-023-05483-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-023-05483-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T13:04:52Z","timestamp":1705583092000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-023-05483-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,18]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["5483"],"URL":"https:\/\/doi.org\/10.1007\/s00296-023-05483-3","relation":{},"ISSN":["1437-160X"],"issn-type":[{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2023,10,18]]},"assertion":[{"value":"3 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there is no conflict of interest regarding this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The patients gave her informed consent for the submission of this case report\/case-based review to the Journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient\u2019s consent"}}]}}